Trials / Completed
CompletedNCT01625533
Safety and Efficacy Study of Dual-axis Rotational Versus Standard Coronary Angiography
Randomized Study on the Safety and Efficacy of Dual-axis Rotational Versus Standard Coronary Angiography
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 576 (actual)
- Sponsor
- General Hospital of Chinese Armed Police Forces · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the clinical safety and efficacy of dual-axis rotational coronary angiography (DARCA) in the diagnosis of coronary artery disease by directly comparing it to standard coronary angiography (SA).
Detailed description
Dual-axis rotational coronary angiography (DARCA) was developed as an innovative adaptation of rotational angiography (RA), but it requires a longer coronary injection compared to standard coronary angiography (SA). The risk of complications from the contrast agent (such as discomfort, warmth, pain, hypotension and bradycardia) is increased with the use of DARCA. It remains to be evaluated whether this approach is also suitable for coronary angiography, especially using in the patients with complex coronary lesions. Previous studies revealed promising results, but the number of patients included did not provide sufficient statistical power to allow a valid comparison of DARCA with SA. The purpose of this study is to evaluate the feasibility, safety, clinical tolerance, and hemodynamic effect of DARCA in comparison to the well-established SA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Standard Coronary Angiography | Using standard coronary angiography (SA) for the diagnosis of coronary artery disease. |
| PROCEDURE | Dual-axis Rotational Coronary Angiography | Using dual-axis rotational coronary angiography (DARCA) for the diagnosis of coronary artery disease. |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2013-07-01
- Completion
- 2013-07-01
- First posted
- 2012-06-21
- Last updated
- 2015-06-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01625533. Inclusion in this directory is not an endorsement.